VolitionRX Limited (VNRX)
(Delayed Data from AMEX)
$0.66 USD
+0.03 (3.94%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.66 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
VolitionRX Limited [VNRX]
Reports for Purchase
Showing records 1 - 20 ( 100 total )
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Snaring sepsis, with early NETs detection
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Unravelling the web of NETs in sepsis
Provider: Edison Investment Research Limited
Analyst: ROMANOFF S
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: RALSTON S
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
New platform format; more proof-of-concept data
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Data with product-grade assays expected soon
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Nu.Q lung cancer test development accelerates
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Multiple partnerships enable diversification
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Shifts in US CRC screening; major catalysts in H2
Provider: Edison Investment Research Limited
Analyst: PECIULIS J
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
(3Q18) and establishing a final panel for the Nu.Q Colorectal Cancer Frontline Screening Test.
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
VolitionRX Ltd. has made significant progress since our last note on both clinical and corporate fronts, as highlighted below.
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A